{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:47:08Z","timestamp":1790488028316,"version":"4.1.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.nbd.2014.07.001","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T17:01:09Z","timestamp":1405443669000},"page":"110-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease"],"prefix":"10.1016","volume":"71","author":[{"given":"Syed Faraz","family":"Kazim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ling","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunn-Chyn","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"LaFerla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge-Grundke","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2014.07.001_bb0005","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1212\/WNL.46.5.1244","article-title":"A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group","volume":"46","author":"ACTSG","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.07.001_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0361-9230(97)00273-6","article-title":"Effect of ciliary neurotrophic factor on body temperature and cerebrospinal fluid prostanoids in the cat","volume":"45","author":"Akarsu","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2014.07.001_bb0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.conb.2011.12.006","article-title":"Regulation of AMPA receptor trafficking and synaptic plasticity","volume":"22","author":"Anggono","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00401-009-0536-x","article-title":"Synaptic degeneration in Alzheimer's disease","volume":"118","author":"Arendt","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0025","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1034\/j.1600-0447.2003.00081.x","article-title":"Prediction of transition from cognitive impairment to senile dementia: a prospective, longitudinal study","volume":"107","author":"Artero","year":"2003","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.nbd.2014.07.001_bb0030","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/dev.20546","article-title":"BDNF control of adult SVZ neurogenesis","volume":"54","author":"Bath","year":"2012","journal-title":"Dev. Psychobiol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0003-2697(76)80064-4","article-title":"Assay of proteins in the presence of interfering materials","volume":"70","author":"Bensadoun","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.nbd.2014.07.001_bb0040","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","article-title":"Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice","volume":"45","author":"Billings","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.07.001_bb0050","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3233\/JAD-2010-1000069","article-title":"Beneficial effect of a CNTF tetrapeptide on adult hippocampal neurogenesis, neuronal plasticity, and spatial memory in mice","volume":"21","author":"Blanchard","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.07.001_bb0055","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00401-010-0734-6","article-title":"Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Abeta and tau pathologies in 3xTg-AD mice","volume":"120","author":"Blanchard","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0045","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/NEN.0b013e318236e9ad","article-title":"Rescue of synaptic failure and alleviation of learning and memory impairments in a trisomic mouse model of down syndrome","volume":"70","author":"Blanchard","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0060","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","article-title":"Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease","volume":"106","author":"Blurton-Jones","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.07.001_bb0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00401-011-0908-x","article-title":"An experimental rat model of sporadic Alzheimer's disease and rescue of cognitive impairment with a neurotrophic peptide","volume":"123","author":"Bolognin","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.nbd.2014.07.001_bb0065","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.neurobiolaging.2014.02.017","article-title":"Rescue of cognitive-aging by administration of a neurogenic and\/or neurotrophic compound","volume":"35","author":"Bolognin","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.07.001_bb0075","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/15258160360732759","article-title":"Growth factor deprivation induces an alternative non-apoptotic death mechanism that is inhibited by Bcl2 in cells derived from neural precursor cells","volume":"12","author":"Cardenas-Aguayo","year":"2003","journal-title":"J. Hematother. Stem Cell Res."},{"key":"10.1016\/j.nbd.2014.07.001_bb0080","doi-asserted-by":"crossref","first-page":"e53596","DOI":"10.1371\/journal.pone.0053596","article-title":"Neurogenic and neurotrophic effects of BDNF peptides in mouse hippocampal primary neuronal cell cultures","volume":"8","author":"Cardenas-Aguayo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.07.001_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainres.2010.10.009","article-title":"Sex differences in \u03b2-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure","volume":"1366","author":"Carroll","year":"2010","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.nbd.2014.07.001_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/1389203013381125","article-title":"Development of neurotrophic molecules for treatment of neurodegeneration","volume":"2","author":"Chen","year":"2001","journal-title":"Curr. Protein Pept. Sci."},{"issue":"8","key":"10.1016\/j.nbd.2014.07.001_bb0090","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.neurobiolaging.2006.05.036","article-title":"Trophic factors counteract elevated FGF-2-induced inhibition of adult neurogenesis","volume":"28","author":"Chen","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.07.001_bb0095","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12035-012-8375-5","article-title":"A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse)","volume":"47","author":"Chen","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0105","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.neurobiolaging.2009.08.008","article-title":"Enhancement of dentate gyrus neurogenesis, dendritic and synaptic plasticity and memory by a neurotrophic peptide","volume":"32","author":"Chohan","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.07.001_bb0110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.nbd.2007.06.013","article-title":"Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice","volume":"28","author":"Clinton","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.07.001_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuropharm.2012.06.051","article-title":"The NMDA receptor as a target for cognitive enhancement","volume":"64","author":"Collingridge","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2014.07.001_bb0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0169-328X(97)00125-3","article-title":"Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain research","volume":"49","author":"Connor","year":"1997","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.nbd.2014.07.001_bb0125","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1038\/cddis.2010.73","article-title":"Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction","volume":"1","author":"Corona","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2014.07.001_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1460-9568.2004.03813.x","article-title":"Doublecortin expression levels in adult brain reflect neurogenesis","volume":"21","author":"Couillard-Despres","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0135","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.07.001_bb0140","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1476-5381.2011.01517.x","article-title":"Sildenafil restores cognitive function without affecting beta-amyloid burden in a mouse model of Alzheimer's disease","volume":"164","author":"Cuadrado-Tejedor","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0145","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.nbd.2011.09.002","article-title":"Activation of glycogen synthase kinase-3 beta mediates beta-amyloid induced neuritic damage in Alzheimer's disease","volume":"45","author":"DaRocha-Souto","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.07.001_bb0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-510X(87)90057-8","article-title":"A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease","volume":"78","author":"Davies","year":"1987","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbr.2013.03.009","article-title":"Episodic-like memory is sensitive to both Alzheimer's-like pathological accumulation and normal ageing processes in mice","volume":"254","author":"Davis","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2014.07.001_bb0160","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2990.2003.00487.x","article-title":"Neurotrophins and neurodegeneration","volume":"29","author":"Dawbarn","year":"2003","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0165","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/jnr.22387","article-title":"Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice","volume":"88","author":"Demars","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2014.07.001_bb0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuropharm.2012.06.047","article-title":"Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence-accelerated mouse model","volume":"64","author":"Dobarro","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2014.07.001_bb0175","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/cne.20840","article-title":"Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease","volume":"495","author":"Donovan","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0180","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/jnc.12011","article-title":"Pharmacological or genetic blockade of the dopamine D3 receptor increases cell proliferation in the hippocampus of adult mice","volume":"123","author":"Egeland","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.07.001_bb0185","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1460-9568.2005.04290.x","article-title":"Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3 Kinase signalling mechanism","volume":"22","author":"Elliott","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0190","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bbr.2009.12.036","article-title":"One-trial objects recognition in rats and mice: methodological and theoritical issues","volume":"215","author":"Ennaceur","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2014.07.001_bb0195","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/156720510790274400","article-title":"Towards disease-modifying treatment of Alzheimer's disease: drugs targeting beta-amyloid","volume":"7","author":"Frisardi","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.nbd.2014.07.001_bb0200","doi-asserted-by":"crossref","first-page":"260925","DOI":"10.1155\/2013\/260925","article-title":"Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approaches","volume":"2013","author":"Fuster-Matanzo","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.nbd.2014.07.001_bb0205","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1523\/JNEUROSCI.4182-09.2010","article-title":"Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease","volume":"30","author":"Garcia","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0210","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2014.07.001_bb0215","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature11775","article-title":"LTP requires a reserve pool of glutamate receptors independent of subunit type","volume":"493","author":"Granger","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.07.001_bb0220","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.07.001_bb0225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0169-328X(88)90017-4","article-title":"Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments","volume":"464","author":"Grundke-Iqbal","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2014.07.001_bb0230","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.07.001_bb0235","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/sj.mp.4001957","article-title":"Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories","volume":"12","author":"Heldt","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2014.07.001_bb0240","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1046\/j.1471-4159.2002.01269.x","article-title":"Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments","volume":"83","author":"Hernandez","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.07.001_bb0245","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2008.03.079","article-title":"Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model","volume":"1216","author":"Hirata-Fukae","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2014.07.001_bb0250","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nbd.2008.10.007","article-title":"GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals","volume":"33","author":"Hu","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.07.001_bb0255","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3233\/JAD-2011-110608","article-title":"Biochemical and morphological characterization of the AbetaPP\/PS\/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease","volume":"27","author":"Hunter","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2014.07.001_bb0265","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jalz.2010.04.006","article-title":"Alzheimer's disease, a multifactorial disorder seeking multitherapies","volume":"6","author":"Iqbal","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2014.07.001_bb0270","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00401-011-0878-z","article-title":"Opportunities and challenges in developing Alzheimer disease therapeutics","volume":"122","author":"Iqbal","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0260","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/ana.20639","article-title":"Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers","volume":"58","author":"Iqbal","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0275","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.ejhg.5201159","article-title":"Ciliary neurotrophic factor (CNTF) genotype and body composition. European journal of human genetics","volume":"12","author":"Jacob","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2014.07.001_bb0280","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0896-6273(00)81122-8","article-title":"Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I","volume":"24","author":"Janz","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.07.001_bb0285","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ana.10506","article-title":"Cerebral neurogenesis is induced by intranasal administration of growth factors","volume":"53","author":"Jin","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0290","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-0270(02)00007-9","article-title":"The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis","volume":"115","author":"Kee","year":"2002","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2014.07.001_bb0295","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3727\/096368910X528085","article-title":"Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn Down syndrome mice","volume":"20","author":"Kern","year":"2010","journal-title":"Cell Transplant."},{"key":"10.1016\/j.nbd.2014.07.001_bb0300","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.neuron.2009.01.015","article-title":"Synaptic AMPA receptor plasticity and behavior","volume":"61","author":"Kessels","year":"2009","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.nbd.2014.07.001_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2013.07.010","article-title":"Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments","volume":"141","author":"King","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2014.07.001_bb0310","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1523\/JNEUROSCI.2868-05.2005","article-title":"Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease","volume":"25","author":"Kitazawa","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0315","doi-asserted-by":"crossref","first-page":"E1339","DOI":"10.1073\/pnas.1102349108","article-title":"FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders","volume":"108","author":"Kiyota","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.07.001_bb0320","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1523\/JNEUROSCI.08-02-00715.1988","article-title":"K-252a: a specific inhibitor of the action of nerve growth factor on PC 12 cells","volume":"8","author":"Koizumi","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0325","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1126\/science.1115360","article-title":"Neurogenesis in the hypothalamus of adult mice: potential role in energy balance","volume":"310","author":"Kokoeva","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.07.001_bb0330","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/NEN.0b013e318221bfab","article-title":"Moderate environmental enrichment mitigates tauopathy in a neurofibrillary tangle mouse model","volume":"70","author":"Lahiani-Cohen","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0340","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/nen.0b013e318160c5db","article-title":"Failure of neuronal maturation in Alzheimer disease dentate gyrus","volume":"67","author":"Li","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0335","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1016\/j.febslet.2010.06.025","article-title":"Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice","volume":"584","author":"Li","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2014.07.001_bb0345","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0306-4522(01)00378-5","article-title":"Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis","volume":"107","author":"Lichtenwalner","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.07.001_bb0350","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/156720507783018316","article-title":"Small molecule neurotrophin receptor ligands: novel strategies for targeting Alzheimer's disease mechanisms","volume":"4","author":"Longo","year":"2007","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"10.1016\/j.nbd.2014.07.001_bb0355","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrn3505","article-title":"BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases","volume":"14","author":"Lu","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0360","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2202-9-117","article-title":"Intranasal delivery of transforming growth factor-beta1 in mice after stroke reduces infarct volume and increases neurogenesis in the subventricular zone","volume":"9","author":"Ma","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0365","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0370","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.09.012","article-title":"LTP and LTD: an embarrassment of riches","volume":"44","author":"Malenka","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.07.001_bb0375","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrn1908","article-title":"The therapeutic potential of neural stem cells","volume":"7","author":"Martino","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0380","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0278-5846(03)00124-6","article-title":"Inflammatory processes in Alzheimer's disease","volume":"27","author":"McGeer","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2014.07.001_bb0385","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0896-6273(03)00368-4","article-title":"Synaptic transmission and plasticity in the absence of AMPA glutamate receptor GluR2 and GluR3","volume":"39","author":"Meng","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.07.001_bb0390","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/297681a0","article-title":"Place navigation impaired in rats with hippocampal lesions","volume":"297","author":"Morris","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.07.001_bb0395","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nm.1912","article-title":"Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease","volume":"15","author":"Nagahara","year":"2009","journal-title":"Nat. Med."},{"issue":"39","key":"10.1016\/j.nbd.2014.07.001_bb0400","doi-asserted-by":"crossref","first-page":"15596","DOI":"10.1523\/JNEUROSCI.5195-12.2013","article-title":"Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice","volume":"33","author":"Nagahara","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0405","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2303","article-title":"Synaptic plasticity, memory and the hippocampus: a neural network approach to causality","volume":"9","author":"Neves","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0410","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.07.001_bb0420","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/11315770-000000000-00000","article-title":"Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators","volume":"26","author":"Panza","year":"2009","journal-title":"Drugs Aging"},{"key":"10.1016\/j.nbd.2014.07.001_bb0425","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/BF03327445","article-title":"Beyond the neurotransmitter-focused approach in treating Alzheimer's disease: drugs targeting beta-amyloid and tau protein","volume":"21","author":"Panza","year":"2009","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.nbd.2014.07.001_bb0415","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2217\/imt.11.170","article-title":"Immunotherapy for Alzheimer's disease: from anti-beta-amyloid to tau-based immunization strategies","volume":"4","author":"Panza","year":"2012","journal-title":"Immunotherapy"},{"key":"10.1016\/j.nbd.2014.07.001_bb0430","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s007020050039","article-title":"Subcellular distribution of protein phosphatases and abnormally phosphorylated tau in the temporal cortex from Alzheimer's disease and control brains","volume":"105","author":"Pei","year":"1998","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2014.07.001_bb0435","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature01640","article-title":"GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides","volume":"423","author":"Phiel","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2014.07.001_bb0440","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.exger.2012.06.013","article-title":"Modulating cognitive deficits and tau accumulation in a mouse model of aging Down syndrome through neonatal implantation of neural progenitor cells","volume":"47","author":"Rachubinski","year":"2012","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0445","doi-asserted-by":"crossref","first-page":"12175","DOI":"10.1073\/pnas.0704091104","article-title":"Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells","volume":"104","author":"Redmond","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.07.001_bb0450","doi-asserted-by":"crossref","first-page":"15472","DOI":"10.1523\/JNEUROSCI.3960-09.2009","article-title":"Brain-derived neurotrophic factor reduces amyloidogenic processing through control of SORLA gene expression","volume":"29","author":"Rohe","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0455","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.1523\/JNEUROSCI.2514-06.2006","article-title":"Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease","volume":"26","author":"Rosario","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0460","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1523\/JNEUROSCI.3741-04.2005","article-title":"Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus","volume":"25","author":"Sairanen","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0465","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0079-6123(07)00009-X","article-title":"The role of the GluR-A (GluR1) AMPA receptor subunit in learning and memory","volume":"169","author":"Sanderson","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2014.07.001_bb0470","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0166-4328(02)00238-3","article-title":"Effects of intra-accumbens focal administrations of glutamate antagonists on object recognition memory in mice","volume":"138","author":"Sargolini","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2014.07.001_bb0480","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","article-title":"Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment","volume":"27","author":"Scheff","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.07.001_bb0475","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","article-title":"Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment","volume":"68","author":"Scheff","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.07.001_bb0485","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.07.001_bb0490","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.nbd.2009.05.025","article-title":"A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo","volume":"35","author":"Sereno","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.07.001_bb0495","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02740642","article-title":"Making sense of the multiple MAP-2 transcripts and their role in the neuron","volume":"16","author":"Shafit-Zagardo","year":"1998","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0500","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00401-011-0843-x","article-title":"Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced A\u03b2 and tau pathology in transgenic mouse models of Alzheimer's disease","volume":"122","author":"Shao","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0505","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s10495-010-0491-y","article-title":"Neurogenesis in the aged and neurodegenerative brain","volume":"15","author":"Shruster","year":"2010","journal-title":"Apoptosis"},{"issue":"4","key":"10.1016\/j.nbd.2014.07.001_bb9000","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neurobiolaging.2008.05.015","article-title":"MRC Cognitive Function and Ageing Neuropathology Study Group. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain","volume":"31","author":"Simpson","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.07.001_bb0510","first-page":"215","article-title":"Release of growth factors by neuronal precursor cells as a treatment for diseases with tau pathology","volume":"149","author":"Spillantini","year":"2011","journal-title":"Arch. Ital. Biol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0515","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00005072-199708000-00011","article-title":"Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease","volume":"56","author":"Sze","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0520","first-page":"371","article-title":"K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors","volume":"7","author":"Tapley","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.nbd.2014.07.001_bb0525","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1523\/JNEUROSCI.19-13-05245.1999","article-title":"Dynamic regulation of expression and phosphorylation of tau by fibroblast growth factor-2 in neural progenitor cells from adult rat hippocampus","volume":"19","author":"Tatebayashi","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0530","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0535","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00308476","article-title":"A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease","volume":"83","author":"Vallet","year":"1992","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0540","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0014-5793(98)01090-4","article-title":"Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase","volume":"436","author":"Wang","year":"1998","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.nbd.2014.07.001_bb0545","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1460-9568.2006.05226.x","article-title":"Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration","volume":"25","author":"Wang","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2014.07.001_bb0550","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archneur.1992.00530290030008","article-title":"Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease","volume":"49","author":"Welsh","year":"1992","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2014.07.001_bb0555","doi-asserted-by":"crossref","first-page":"a006346","DOI":"10.1101\/cshperspect.a006346","article-title":"Inflammation in Alzheimer disease\u2014a brief review of the basic science and clinical literature","volume":"2","author":"Wyss-Coray","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.nbd.2014.07.001_bb0560","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0028-3908(02)00043-6","article-title":"Neurotrophins induce BDNF expression through the glutamate receptor pathway in neocortical neurons","volume":"42","author":"Xiong","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2014.07.001_bb0565","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1126\/science.284.5421.1805","article-title":"Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning","volume":"284","author":"Zamanillo","year":"1999","journal-title":"Science"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114001958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114001958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T17:22:12Z","timestamp":1565630532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996114001958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":114,"alternative-id":["S0969996114001958"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2014.07.001","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2014.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}